SEC Form 4/A · accession 0001179110-19-000576
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Andrew A. F. Hack
Officer — Chief Financial Officer
Period of report
Nov 23, 2018
Accepted (ET)
Jan 8, 2019 · 5:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001650664
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 23, 2018 | M | 5,284 | $3.23 | A | 5,284 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F3 | $3.23 | Nov 23, 2018 | M | 5,284 | D | — | Jul 13, 2025 | Common Stock | 5,284 | 119,143 | D |
| Stock Option (right to buy)F4,F5 | $6.48 | holding | — | — | — | — | Sep 13, 2025 | Common Stock | 23,513 | 23,513 | D |
Explanation of responses
- F1The Reporting Person is filing this amended Form 4 to amend the Form 4 filed by the Reporting Person with the SEC on November 27, 2018, which inadvertently reported the exercise of a different stock option held by the Reporting Person. This amended Form 4 now reflects the correct information regarding the option that was exercised.
- F2The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 29, 2018.
- F3This option was granted on July 14, 2015 and is scheduled to vest over four years with 25% of the shares having vested on July 1, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 1, 2019.
- F4The Form 4 filed by the Reporting Person with the SEC on November 27, 2018 erroneously reported this option as having been exercised. This amended Form 4 now includes the correct information regarding the portion of this option that was outstanding as of the date of the transactions reported on this amended Form 4.
- F5This option was granted on September 14, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on July 1, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 1, 2019.